ESSA Pharma Inc.·4

Nov 1, 11:05 AM ET

Glickman Richard M 4

4 · ESSA Pharma Inc. · Filed Nov 1, 2022

Insider Transaction Report

Form 4
Period: 2022-06-29
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-29+35,00035,000 total
    Exercise: $3.60Exp: 2032-06-29Common Shares (35,000 underlying)
Footnotes (1)
  • [F1]100% of the options vest after 12 months from the date of grant.

Documents

2 files